MedTrace Logo

Training Caregivers to Teach Vocabulary to Children With Language Impairment

NCT07519629 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2026-04-09

No results posted yet for this study

Summary

The purpose of this study is to determine whether Spanish-speaking caregivers can learn to teach science vocabulary to their children with the use and educational app and a short training video with target words. The children will take language, speech, and hearing tests, as well as science and vocabulary pretests with a speech-language pathologist. You will be asked to answer some questions about your language use in the house and other places. If you and your child qualify for the study, the researcher will randomly place you a group to 1) use the app, or 2) use books. Since you are chosen at random, there is no way of knowing which group you and your child will be in before you start. Participants will take part in an 11-week study (3 weeks of testing at the beginning, middle, and end of study, and 8 weeks of intervention). The testing will be conducted in a place that is comfortable for your child (home, school, university clinic). The intervention can be done at home (researchers will not be present for this part of the study, but we will be available to support you or answer questions). We want you to play (group 1) or read (group 2) with your child two times a week (\~30 minutes) and send the audio recording of your interaction to our researchers.

Conditions

  • Developmental Language Disorder

Interventions

BEHAVIORAL

Robust vocabulary intervention

Caregivers will be trained to teach target vocabulary to their children

Sponsors & Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • Northern Arizona University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-23
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07519629 on ClinicalTrials.gov